[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
[2] |
Feng RM, Zong YN, Cao SM, et al. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?[J]. Cancer Commun, 2019, 39(1):22.
|
[3] |
Wu MC, Shen F. Progress in research of liver surgery in China[J]. World J Gastroenterol, 2000, 6(6):773-776.
|
[4] |
Sun HC, Zhuang PY, Qin LX, et al. Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy[J]. J Surg Oncol, 2007, 96(1):37-45.
|
[5] |
Shen XH, Li HK, Wang F, et al. Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma[J]. World J Surg, 2010, 34(5):1028-1033.
|
[6] |
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[J]. Cell, 2010, 140(6):883-899.
|
[7] |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5):646-674.
|
[8] |
Lee S, Song A, Eo W. Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal cancer[J].J Cancer, 2016, 7(8):957-964.
|
[9] |
Chen Y, Chen K, Xiao X, et al. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study[J]. BMC Cancer, 2016(16):320.
|
[10] |
Wu SJ, Lin YX, Ye H, et al. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy[J]. J Surg Oncol, 2016, 114(2):202-210.
|
[11] |
Gu XB, Gao XS, Cui M, et al. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer[J]. Oncotarget, 2016, 7(31):49878-49887.
|
[12] |
Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches[J]. Proc Natl Acad Sci U S A, 2014, 111(30): E3053-3061.
|
[13] |
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203):436-444.
|
[14] |
Asano Y, Kashiwagi S, Onoda N, et al. Platelet-lymphocyte ratio as a useful predictor of the therapeutic effect of neoadjuvant chemotherapy in breast cancer[J]. PLoS One, 2016, 11(7): e0153459.
|
[15] |
You J, Zhu GQ, Xie L, et al. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer[J]. Oncotarget, 2016, 7(18):25516-25527.
|
[16] |
Goh BK, Kam JH, Lee SY, et al. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma[J].J Surg Oncol, 2016, 113(6):621-627.
|
[17] |
Hung HH, Su CW, Lai CR, et al. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary smallhepatitis B-related hepatocellular carcinoma[J]. Hepatol Int, 2010, 4(4):691-699.
|